NEW YORK (GenomeWeb News) – Wasatch Microfluidics is in the process of raising $1 million in a Series B round that is expected to close within the next three weeks, its president said.

Earlier this week, Pasadena Angels announced it had invested $475,000 in the round, and today Wasatch President Josh Eckman told GenomeWeb Daily News that the financing will be used primarily to build up the firm's sales and marketing operations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.